These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22322956)

  • 1. Treatment management of small renal masses in the 21st century: a paradigm shift.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic disparities in the treatment of small renal masses.
    Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
    Baillargeon-Gagné S; Jeldres C; Lughezzani G; Sun M; Isbarn H; Capitanio U; Shariat SF; Crépel M; Alasker A; Widmer H; Arjane P; Patard JJ; Perrotte P; Montorsi F; Graefen M; Karakiewicz PI
    BJU Int; 2010 Feb; 105(3):359-64. PubMed ID: 20089096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of partial nephrectomy in European tertiary care centers.
    Zini L; Patard JJ; Capitanio U; Mejean A; Villers A; de La Taille A; Ficarra V; Crepel M; Bertini R; Salomon L; Verhoest G; Perrotte P; Bensalah K; Arjane P; Biserte J; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2009 Jun; 35(6):636-42. PubMed ID: 18775626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
    Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
    Vricella GJ; Finelli A; Alibhai SM; Ponsky LE; Abouassaly R
    BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.